La maladie de Parkinson en France (serveur d'exploration) - Merge (Accueil)

Index « Auteurs » - entrée « D. Scherman »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
D. Savrina < D. Scherman < D. Scholefield  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
005002 (1995) M. Ruberg [France] ; D. Scherman ; F. Javoy-Agid ; Yves Agid [France]Dopamine denervation, age of onset, and Parkinson's disease.
005212 (1995) M. Ruberg [France] ; D. Scherman [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Dopamine denervation, age on onset, and Parkinson's disease
005253 (1994) S. Lehéricy [France] ; J P Brandel ; E C Hirsch ; P. Anglade ; J. Villares ; D. Scherman ; C. Duyckaerts ; F. Javoy-Agid ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.
005438 (1994) S. Lehericy [France] ; J.-P. Brandel [France] ; E. C. Hirsch [France] ; P. Anglade [France] ; J. Villares [France] ; D. Scherman [France] ; C. Duyckaerts [France] ; F. Javoy-Agid [France] ; Yves Agid [France]Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography
005A84 (1990) P. Horellou [France] ; L. Marlier ; A. Privat ; F. Darchen ; D. Scherman ; J P Henry ; J. MalletExogeneous expression of L-dopa and dopamine in various cell lines following transfer of rat and human tyrosine hydroxylase cDNA: grafting in an animal model of Parkinson's disease.
005D45 (1989) D. Scherman ; C. Desnos ; F. Darchen ; P. Pollak ; F. Javoy-Agid ; Yves Agid [France]Striatal dopamine deficiency in Parkinson's disease: role of aging
005D65 (1988) L. Pierot [France] ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Yves Agid [France]D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.
005E56 (1988) L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Yves Agid [France]D1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy
005E58 (1988) D. Scherman ; F. Darchen ; C. Desnos ; J. P. Henry1-Methyl-4-phenylpyridinium is a substrate of the vesicular monoamine uptake system of chromaffin granules

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i -k "D. Scherman" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/Author.i  \
                -Sk "D. Scherman" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Merge
   |type=    indexItem
   |index=    Author.i
   |clé=    D. Scherman
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024